Ebusco Holding NV
F:8J3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ebusco Holding NV
F:8J3
|
NL |
|
B
|
Belden Inc
F:QCTA
|
US |
|
Research Solutions Inc
F:61I
|
US |
|
Nanobiotix SA
F:5NR
|
FR |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Perma-Pipe International Holdings Inc
F:MF3
|
US |
Wall St Price Targets
8J3 Price Targets Summary
Ebusco Holding NV
According to Wall Street analysts, the average 1-year price target for
8J3 is 1.77 EUR with a low forecast of 1.75 EUR and a high forecast of 1.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8J3's stock price target?
Price Target
1.77
EUR
According to Wall Street analysts, the average 1-year price target for
8J3 is 1.77 EUR with a low forecast of 1.75 EUR and a high forecast of 1.82 EUR.
What is the Revenue forecast for Ebusco Holding NV?
Projected CAGR
513%
Over the last 5 years, the compound annual growth rate for Revenue has been -26%. The projected CAGR for the next 2 years is 513%.